Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEAYA Biosciences, Inc. Director's Dealing 2023

Feb 28, 2023

31547_dirs_2023-02-28_8b516427-7e48-43b4-9b4f-2aa6fd815fe8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEAYA Biosciences, Inc. (IDYA)
CIK: 0001676725
Period of Report: 2023-02-24

Reporting Person: Stone Paul A. (Chief Financial Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-02-24 Stock Option (right to buy) $17.04 A 140000 Acquired 2033-02-23 Common Stock (140000) Direct

Footnotes

F1: 25% of the shares subject to the option vest on the first anniversary measured from January 1, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.